BERLIN, June 24 /PRNewswire/ --

- Easier Market Access for Israeli Companies - German Investment Promotion Agency to Hold Seminar in Tel Aviv

Germany is Europe's largest market for medical devices, and recent trends are strengthening this position. Germany's inward investment promotion agency, Invest in Germany, will discuss the advantages of Germany as an investment location at a seminar in Tel Aviv on June 25, 2008.

Germany's market for medical devices has grown by seven percent annually over the last 10 years. The combination of a highly educated workforce in the sciences, comprehensive public health care system, and internationally renowned research networks is strengthening this leading position. Furthermore, an investment in Germany opens the door to the nearly 500 million customers in the European Union (EU). Addressing this vast market from a central EU location could boost EU sales of Israeli medical devices companies, who have sometimes found it difficult to enter Europe from their home base due to existing regulations and bureaucratic hurdles. Invest in Germany will also specifically address this topic at the seminar.

The seminar is being run in cooperation with the Israeli-German Chamber of Industry and Commerce. Invest in Germany's representative at the event, Dr. Tilo Mandry, is a trained attorney with a broad knowledge of the international pharmaceuticals and medical devices markets. He will discuss the German government's R&D programs as well as other issues impacting upon investments in the health care and medical devices industries: financial support, partnering, and finding clusters.

Dr. Mandry will be joined at the podium by Dr. Hubertus Rosery. Dr. Rosery is one of Germany's foremost consultants for medical devices companies. His talk will address how global medical devices firms can profit from Germany's health care reimbursement system and benefit from Germany's regulatory framework. In particular, he will elaborate on the importance of correctly coding a device within the national coding system for correct manufacturer reimbursement.

Germany's stellar research and development (R&D) environment is helping it stay on the cutting-edge of product development, and is further maintaining its trusted position as an industry leader. The average company in Germany commits nine percent of sales revenue to R&D projects. Furthermore, the German government is working to ensure that Germany maintains its leading position as a location for R&D in the medical technologies industry. As part of Germany's "high-tech strategy," public authorities are making EUR 800 million available for R&D in medical technologies through 2009.

While Germany has many leading international medical technology companies, such as Siemens Medical Solutions or Fresenius AG, there remains plenty of room in the market for smaller entries. Eighty-six percent of medical device companies in Germany have fewer than 100 employees. In addition, Germany's system of public incentives favors smaller firms. In some parts of the country, 50 percent of investment costs are covered by government incentives.

A large and growing market, a trusted name worldwide, and a strong R&D framework are all reasons for Israeli companies to invest in Germany. To attend the seminar, please contact Beatrice Geier at the Israeli-German Chamber of Industry and Commerce, Phone: +972-(0)3-613-35-16 or email

To attend the seminar, please contact Beatrice Geier at the Israeli-German Chamber of Industry and Commerce, Phone: +972(0)3-613-35-16 or email